RelB controls adaptive responses of astrocytes during sterile inflammation

In response to brain injury or infections, astrocytes become reactive, undergo striking morphological and functional changes, and secrete and respond to a spectrum of inflammatory mediators. We asked whether reactive astrocytes also display adaptive responses during sterile IL‐1β‐induced neuroinflam...

Full description

Saved in:
Bibliographic Details
Published inGlia Vol. 67; no. 8; pp. 1449 - 1461
Main Authors Gupta, Angela S., Waters, Michael R., Biswas, Debolina D., Brown, Lashardai N., Surace, Michael J., Floros, Constantinos, Siebenlist, Ulrich, Kordula, Tomasz
Format Journal Article
LanguageEnglish
Published Hoboken, USA John Wiley & Sons, Inc 01.08.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:In response to brain injury or infections, astrocytes become reactive, undergo striking morphological and functional changes, and secrete and respond to a spectrum of inflammatory mediators. We asked whether reactive astrocytes also display adaptive responses during sterile IL‐1β‐induced neuroinflammation, which may limit tissue injury associated with many disorders of the central nervous system. We found that astrocytes display days‐to‐weeks long specific tolerance of cytokine genes, which is coordinated by NF‐κB family member, RelB. However, in contrast to innate immune cells, astrocytic tolerance does not involve epigenetic silencing of the cytokine genes. Establishment of tolerance depends on persistent higher levels of RelB in tolerant astrocytes and its phosphorylation on serine 472. Mechanistically, this phosphorylation prevents efficient removal of RelB from cytokine promoters by IκBα and helps to establish tolerance. Importantly, ablation of RelB from astrocytes in mice abolishes tolerance during experimental neuroinflammation in vivo. Main Points Astrocytes display days‐to‐weeks long tolerance of cytokine genes in vitro and in vivo. This tolerance is coordinated by an NF‐κB family member RelB. Deletion of RelB from astrocytes abolishes tolerance during experimental neuroinflammation in vivo.
Bibliography:Funding information
National Cancer Institute, Grant/Award Numbers: F30CA200252, F30CA203447, P30CA016059; National Institute of Allergy and Infectious Diseases, Grant/Award Number: R01AI093718; National Institute of Neurological Disorders and Stroke, Grant/Award Number: R21NS100698; Intramural Research Program of the NIAID/NIH
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0894-1491
1098-1136
DOI:10.1002/glia.23619